NCT05651282 2026-04-13
RESToRE
University of British Columbia
Phase 4 Completed
Clinical Trials
12 trialsNCT07281547 2026-02-18
Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain
Mayo Clinic
Phase 4 Not yet recruiting
NCT06897527 2025-07-08
A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)
GlaxoSmithKline
Phase 4 Not yet recruiting
NCT06871787 2025-03-14
INOCA
Istanbul University
Phase 4 Not yet recruiting
NCT06726291 2024-12-10
NOEME
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 4 Recruiting
NCT06049693 2024-03-29
IROGYN
National and Kapodistrian University of Athens
Phase 4 Completed
NCT05949424 2023-11-29
OPTI-DOSE
University Medical Center Groningen
Phase 4 Unknown
NCT03349463 2020-02-28
Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.
Loyola University
Phase 4 Unknown
NCT03752606 2018-11-26
Application of Tachosil During Lymphadenectomy
Medical University of Lublin
Phase 4 Completed
NCT02543710 2017-03-28
Momatec2
Haukeland University Hospital
Phase 4 Recruiting
NCT02872818 2016-08-23
Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia
Kayseri Education and Research Hospital
Phase 4 Completed
NCT00190697 2007-05-25
A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment
Eli Lilly and Company
Phase 4 Completed